Independent communications and public affairs consultancy Hanover has launched a new market access practice within its UK and European health team.
The new practice will be led by director Jing Wang-Silvanto, who has over 15 years’ experience in health economics outcomes research (HEOR) and market access, and previously held senior market access and HEOR positions at Bristol-Myers Squibb in the UK, and globally at GSK and Novartis.
Market Access will sit alongside Hanover’s health comms and UK and European policy and advocacy teams in London and Brussels.
Andrew Harrison, MD of health at Hanover, said: “Health system finances are squeezed and there is increased need for companies to demonstrate the value of their products and services. There are plenty of market access consultancies, but Hanover’s ability to join market access with award winning policy, advocacy and communications campaigns provides a unique offer that can bring change for clients.
“Market Access is a natural extension of Hanover’s health work. For a while clients have asked the team to support pricing, health economics and early access work.”
Hanover Health is reportedly a £3.7m revenue business within the Hanover Group, and revenue has increased by over 40% in 2016.